Literature DB >> 21216000

Effect of circumcision of HIV-negative men on transmission of human papillomavirus to HIV-negative women: a randomised trial in Rakai, Uganda.

Maria J Wawer1, Aaron A R Tobian, Godfrey Kigozi, Xiangrong Kong, Patti E Gravitt, David Serwadda, Fred Nalugoda, Frederick Makumbi, Victor Ssempiija, Nelson Sewankambo, Stephen Watya, Kevin P Eaton, Amy E Oliver, Michael Z Chen, Steven J Reynolds, Thomas C Quinn, Ronald H Gray.   

Abstract

BACKGROUND: Randomised trials show that male circumcision reduces the prevalence and incidence of high-risk human papillomavirus (HPV) infection in men. We assessed the efficacy of male circumcision to reduce prevalence and incidence of high-risk HPV in female partners of circumcised men.
METHODS: In two parallel but independent randomised controlled trials of male circumcision, we enrolled HIV-negative men and their female partners between 2003 and 2006, in Rakai, Uganda. With a computer-generated random number sequence in blocks of 20, men were assigned to undergo circumcision immediately (intervention) or after 24 months (control). HIV-uninfected female partners (648 of men from the intervention group, and 597 of men in the control group) were simultaneously enrolled and provided interview information and self-collected vaginal swabs at baseline, 12 months, and 24 months. Vaginal swabs were tested for high-risk HPV by Roche HPV Linear Array. Female HPV infection was a secondary endpoint of the trials, assessed as the prevalence of high-risk HPV infection 24 months after intervention and the incidence of new infections during the trial. Analysis was by intention-to-treat. An as-treated analysis was also done to account for study-group crossovers. The trials were registered, numbers NCT00425984 and NCT00124878.
FINDINGS: During the trial, 18 men in the control group underwent circumcision elsewhere, and 31 in the intervention group did not undergo circumcision. At 24-month follow-up, data were available for 544 women in the intervention group and 488 in the control group; 151 (27·8%) women in the intervention group and 189 (38·7%) in the control group had high-risk HPV infection (prevalence risk ratio=0·72, 95% CI 0·60-0·85, p=0·001). During the trial, incidence of high-risk HPV infection in women was lower in the intervention group than in the control group (20·7 infections vs 26·9 infections per 100 person-years; incidence rate ratio=0·77, 0·63-0·93, p=0·008).
INTERPRETATION: Our findings indicate that male circumcision should now be accepted as an efficacious intervention for reducing the prevalence and incidence of HPV infections in female partners. However, protection is only partial; the promotion of safe sex practices is also important. FUNDING: The Bill & Melinda Gates Foundation, National Institutes of Health, and Fogarty International Center. Copyright Â
© 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21216000      PMCID: PMC3119044          DOI: 10.1016/S0140-6736(10)61967-8

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  29 in total

1.  Male circumcision decreases acquisition and increases clearance of high-risk human papillomavirus in HIV-negative men: a randomized trial in Rakai, Uganda.

Authors:  Ronald H Gray; David Serwadda; Xiangrong Kong; Frederick Makumbi; Godfrey Kigozi; Patti E Gravitt; Stephen Watya; Fred Nalugoda; Victor Ssempijja; Aaron A R Tobian; Noah Kiwanuka; Lawrence H Moulton; Nelson K Sewankambo; Steven J Reynolds; Thomas C Quinn; Boaz Iga; Oliver Laeyendecker; Amy E Oliver; Maria J Wawer
Journal:  J Infect Dis       Date:  2010-05-15       Impact factor: 5.226

2.  Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008.

Authors:  Jacques Ferlay; Hai-Rim Shin; Freddie Bray; David Forman; Colin Mathers; Donald Maxwell Parkin
Journal:  Int J Cancer       Date:  2010-12-15       Impact factor: 7.396

3.  Case-control study of risk factors for cervical neoplasia in Denmark. I: Role of the "male factor" in women with one lifetime sexual partner.

Authors:  S K Kjaer; E M de Villiers; C Dahl; G Engholm; J E Bock; B F Vestergaard; E Lynge; O M Jensen
Journal:  Int J Cancer       Date:  1991-04-22       Impact factor: 7.396

4.  Male circumcision, penile human papillomavirus infection, and cervical cancer in female partners.

Authors:  Xavier Castellsagué; F Xavier Bosch; Nubia Muñoz; Chris J L M Meijer; Keerti V Shah; Silvia de Sanjose; José Eluf-Neto; Corazon A Ngelangel; Saibua Chichareon; Jennifer S Smith; Rolando Herrero; Victor Moreno; Silvia Franceschi
Journal:  N Engl J Med       Date:  2002-04-11       Impact factor: 91.245

5.  The male factor in the etiology of cervical cancer among sexually monogamous women.

Authors:  L A Brinton; W C Reeves; M M Brenes; R Herrero; E Gaitan; F Tenorio; R C de Britton; M Garcia; W E Rawls
Journal:  Int J Cancer       Date:  1989-08-15       Impact factor: 7.396

6.  Epidemiologic classification of human papillomavirus types associated with cervical cancer.

Authors:  Nubia Muñoz; F Xavier Bosch; Silvia de Sanjosé; Rolando Herrero; Xavier Castellsagué; Keerti V Shah; Peter J F Snijders; Chris J L M Meijer
Journal:  N Engl J Med       Date:  2003-02-06       Impact factor: 91.245

7.  Circumcision in HIV-infected men and its effect on HIV transmission to female partners in Rakai, Uganda: a randomised controlled trial.

Authors:  Maria J Wawer; Frederick Makumbi; Godfrey Kigozi; David Serwadda; Stephen Watya; Fred Nalugoda; Dennis Buwembo; Victor Ssempijja; Noah Kiwanuka; Lawrence H Moulton; Nelson K Sewankambo; Steven J Reynolds; Thomas C Quinn; Pius Opendi; Boaz Iga; Renee Ridzon; Oliver Laeyendecker; Ronald H Gray
Journal:  Lancet       Date:  2009-07-18       Impact factor: 79.321

8.  Evaluation of genital sites and sampling techniques for detection of human papillomavirus DNA in men.

Authors:  Bethany A Weaver; Qinghua Feng; King K Holmes; Nancy Kiviat; Shu-Kuang Lee; Christine Meyer; Mike Stern; Laura A Koutsky
Journal:  J Infect Dis       Date:  2004-01-29       Impact factor: 5.226

9.  Incident HIV and herpes simplex virus type 2 infection among men in Rakai, Uganda.

Authors:  Aaron A R Tobian; Victor Ssempijja; Godfrey Kigozi; Amy E Oliver; David Serwadda; Frederick Makumbi; Frederick K Nalugoda; Boaz Iga; Steven J Reynolds; Maria J Wawer; Thomas C Quinn; Ronald H Gray
Journal:  AIDS       Date:  2009-07-31       Impact factor: 4.177

10.  Male circumcision for the prevention of acquisition and transmission of sexually transmitted infections: the case for neonatal circumcision.

Authors:  Aaron A R Tobian; Ronald H Gray; Thomas C Quinn
Journal:  Arch Pediatr Adolesc Med       Date:  2010-01
View more
  95 in total

1.  Male circumcision and herpes simplex virus type 2 infection in female partners: a randomized trial in Rakai, Uganda.

Authors:  Aaron A R Tobian; Godfrey Kigozi; Andrew D Redd; David Serwadda; Xiangrong Kong; Amy Oliver; Fred Nalugoda; Thomas C Quinn; Ronald H Gray; Maria J Wawer
Journal:  J Infect Dis       Date:  2011-12-05       Impact factor: 5.226

Review 2.  Effects of circumcision on male sexual functions: a systematic review and meta-analysis.

Authors:  Ye Tian; Wei Liu; Jian-Zhong Wang; Romel Wazir; Xuan Yue; Kun-Jie Wang
Journal:  Asian J Androl       Date:  2013-06-10       Impact factor: 3.285

3.  Circumcision and non-HIV sexually transmitted infections.

Authors:  Andrew E Macneily; Kourosh Afshar
Journal:  Can Urol Assoc J       Date:  2011-02       Impact factor: 1.862

4.  The effect of medical male circumcision on urogenital Mycoplasma genitalium among men in Kisumu, Kenya.

Authors:  Supriya D Mehta; Charlotte Gaydos; Ian Maclean; Elijah Odoyo-June; Stephen Moses; Lawrence Agunda; Nicole Quinn; Robert C Bailey
Journal:  Sex Transm Dis       Date:  2012-04       Impact factor: 2.830

5.  Human papillomavirus incidence and clearance among HIV-positive and HIV-negative men in sub-Saharan Africa.

Authors:  Aaron A R Tobian; Godfrey Kigozi; Patti E Gravitt; Changchang Xiao; David Serwadda; Kevin P Eaton; Xiangrong Kong; Maria J Wawer; Fred Nalugoda; Thomas C Quinn; Ronald H Gray
Journal:  AIDS       Date:  2012-07-31       Impact factor: 4.177

Review 6.  Voluntary medical male circumcision: an HIV prevention priority for PEPFAR.

Authors:  Jason Bailey Reed; Emmanuel Njeuhmeli; Anne Goldzier Thomas; Melanie C Bacon; Robert Bailey; Peter Cherutich; Kelly Curran; Kim Dickson; Tim Farley; Catherine Hankins; Karin Hatzold; Jessica Justman; Zebedee Mwandi; Luke Nkinsi; Renee Ridzon; Caroline Ryan; Naomi Bock
Journal:  J Acquir Immune Defic Syndr       Date:  2012-08-15       Impact factor: 3.731

7.  [Male circumcision from an infectiological point of view].

Authors:  H Schöfer
Journal:  Hautarzt       Date:  2015-01       Impact factor: 0.751

8.  Sexually transmitted infections and male circumcision: a systematic review and meta-analysis.

Authors:  Robert S Van Howe
Journal:  ISRN Urol       Date:  2013-04-16

9.  Male circumcision: integrating tradition and medical evidence.

Authors:  Seema Kacker; Aaron A R Tobian
Journal:  Isr Med Assoc J       Date:  2013-01       Impact factor: 0.892

Review 10.  Does HIV Exploit the Inflammatory Milieu of the Male Genital Tract for Successful Infection?

Authors:  Rachel T Esra; Abraham J Olivier; Jo-Ann S Passmore; Heather B Jaspan; Rushil Harryparsad; Clive M Gray
Journal:  Front Immunol       Date:  2016-06-24       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.